Here are the 10-Q quarterly reports from HCM IV Acquisition Corp. (HACQ) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HACQ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HACQ filings page.
HCM IV Acquisition Corp., a Cayman Islands-based special purpose acquisition company, completed its February 2026 IPO of 28,750,000 units at $10.00 per unit, raising $287.5 million. After offering costs, $287,500,000 was deposited into a Trust Account, which totaled $291,161,379 including interest as of June 30, 2026, invested mainly in U.S. Treasury Bills.
For the quarter ended June 30, 2026, the company reported net income of $1,889,014, driven by $2,650,081 of interest on Trust investments, offset by $770,227 of general and administrative costs. For the six-month period, it recorded a net loss of $1,057,842, largely due to a one-time $3,062,500 advisory fee expense and ongoing public-company costs.
HCM IV reported $814,444 in cash outside the Trust and a working capital deficit of $404,061. All 28,750,000 Class A shares are classified as redeemable at an aggregate redemption value of $291,161,379. Management states it has not yet identified a business combination target and discloses that limited liquidity and ongoing expenses raise substantial doubt about its ability to continue as a going concern without completing a business combination or securing additional financing.
HCM IV Acquisition Corp., a newly formed SPAC, completed its initial public offering in February 2026 and is still in the pre‑deal stage. The company sold 28,750,000 units at $10.00 each, placing $287.5 million into a trust account invested mainly in U.S. Treasury Bills. As of March 31, 2026, trust assets totaled $288.5 million, reflecting interest income.
For the quarter ended March 31, 2026, HCM reported a net loss of $2.95 million, driven primarily by a $3.06 million advisory fee expense and $0.90 million of general and administrative costs, partially offset by $1.01 million of interest income on the trust investments. All 28,750,000 Class A ordinary shares are classified as redeemable at about $10.04 per share, leading to a shareholders’ deficit of $16.6 million.
The company held $1.02 million in cash and working capital of $338,881 outside the trust, which it uses for ongoing operating and deal‑search expenses. Management discloses that these limited resources raise substantial doubt about its ability to continue as a going concern for one year from issuance, absent completing a business combination or obtaining additional financing. No business combination target has yet been selected, and there are no revenues from operations at this stage.